REPORT ID 15557

Global Antisense and RNAi Therapeutics Market Professional SurveyReport 2019

Publish Date
2019
Pages
116
Format
Electronic (PDF)

This report studies Antisense and RNAi Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Glaxo Smith Kline
    Sanofi Aventis / Genzyme
    Isis Pharmaceuticals/ Ionis Pharmaceuticals
    Arbutus Biopharma Ltd.
    Silence Therapeutics
    Bio-Path Holdings Inc.
    Calando Pharmaceuticals
    ICo Therapeutics
    Quark Pharmaceuticals
    Rexhan Pharmaceuticals
    Biomarin/Prosensa
    Regulus Therapeutics
    Rxi Pharmaceuticals
    Silenseed
    Dicerna Pharmaceuticals
    Sirnaomics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    RNA interference
    SiRNA
    MiRNA
    Antisense RNA

By Application, the market can be split into
    Oncology
    Cardiovascular
    Renal
    Neurodegenerative
    Respiratory
    Genetic
    Infectious Diseases

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Antisense and RNAi Therapeutics Market Professional Survey  Report 2019
1 Industry Overview of Antisense and RNAi Therapeutics
    1.1 Definition and Specifications of Antisense and RNAi Therapeutics
        1.1.1 Definition of Antisense and RNAi Therapeutics
        1.1.2 Specifications of Antisense and RNAi Therapeutics
    1.2 Classification of Antisense and RNAi Therapeutics
        1.2.1 RNA interference
        1.2.2 SiRNA
        1.2.3 MiRNA
        1.2.4 Antisense RNA
    1.3 Applications of Antisense and RNAi Therapeutics
        1.3.1 Oncology
        1.3.2 Cardiovascular
        1.3.3 Renal
        1.3.4 Neurodegenerative
        1.3.5 Respiratory
        1.3.6 Genetic
        1.3.7 Infectious Diseases
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Antisense and RNAi Therapeutics
    2.3 Manufacturing Process Analysis of Antisense and RNAi Therapeutics
    2.4 Industry Chain Structure of Antisense and RNAi Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Antisense and RNAi Therapeutics
    3.1 Capacity and Commercial Production Date of Global Antisense and RNAi Therapeutics Major Manufacturers  in 2018
    3.2 Manufacturing Plants Distribution of Global Antisense and RNAi Therapeutics Major Manufacturers  in 2018
    3.3 R&D Status and Technology Source of Global Antisense and RNAi Therapeutics Major Manufacturers  in 2018
    3.4 Raw Materials Sources Analysis of Global Antisense and RNAi Therapeutics Major Manufacturers  in 2018

4 Global Antisense and RNAi Therapeutics Overall Market Overview
    4.1  2014-2019E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1  2014-2019E Global Antisense and RNAi Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2016 Antisense and RNAi Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1  2014-2019E Global Antisense and RNAi Therapeutics Sales and Growth Rate Analysis
        4.3.2 2016 Antisense and RNAi Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1  2014-2019E Global Antisense and RNAi Therapeutics Sales Price
        4.4.2 2016 Antisense and RNAi Therapeutics Sales Price Analysis (Company Segment)

5 Antisense and RNAi Therapeutics Regional Market Analysis
    5.1 North America Antisense and RNAi Therapeutics Market Analysis
        5.1.1 North America Antisense and RNAi Therapeutics Market Overview
        5.1.2 North America  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.1.4 North America 2016 Antisense and RNAi Therapeutics Market Share Analysis
    5.2 China Antisense and RNAi Therapeutics Market Analysis
        5.2.1 China Antisense and RNAi Therapeutics Market Overview
        5.2.2 China  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.2.4 China 2016 Antisense and RNAi Therapeutics Market Share Analysis
    5.3 Europe Antisense and RNAi Therapeutics Market Analysis
        5.3.1 Europe Antisense and RNAi Therapeutics Market Overview
        5.3.2 Europe  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.3.4 Europe 2016 Antisense and RNAi Therapeutics Market Share Analysis
    5.4 Southeast Asia Antisense and RNAi Therapeutics Market Analysis
        5.4.1 Southeast Asia Antisense and RNAi Therapeutics Market Overview
        5.4.2 Southeast Asia  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.4.4 Southeast Asia 2016 Antisense and RNAi Therapeutics Market Share Analysis
    5.5 Japan Antisense and RNAi Therapeutics Market Analysis
        5.5.1 Japan Antisense and RNAi Therapeutics Market Overview
        5.5.2 Japan  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.5.4 Japan 2016 Antisense and RNAi Therapeutics Market Share Analysis
    5.6 India Antisense and RNAi Therapeutics Market Analysis
        5.6.1 India Antisense and RNAi Therapeutics Market Overview
        5.6.2 India  2014-2019E Antisense and RNAi Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India  2014-2019E Antisense and RNAi Therapeutics Sales Price Analysis
        5.6.4 India 2016 Antisense and RNAi Therapeutics Market Share Analysis

6 Global  2014-2019E Antisense and RNAi Therapeutics Segment Market Analysis (by Type)
    6.1 Global  2014-2019E Antisense and RNAi Therapeutics Sales by Type
    6.2 Different Types of Antisense and RNAi Therapeutics Product Interview Price Analysis
    6.3 Different Types of Antisense and RNAi Therapeutics Product Driving Factors Analysis
        6.3.1 RNA interference of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        6.3.2 SiRNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        6.3.3 MiRNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        6.3.4 Antisense RNA of Antisense and RNAi Therapeutics Growth Driving Factor Analysis

7 Global  2014-2019E Antisense and RNAi Therapeutics Segment Market Analysis (by Application)
    7.1 Global  2014-2019E Antisense and RNAi Therapeutics Consumption by Application
    7.2 Different Application of Antisense and RNAi Therapeutics Product Interview Price Analysis
    7.3 Different Application of Antisense and RNAi Therapeutics Product Driving Factors Analysis
        7.3.1 Oncology of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.2 Cardiovascular of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.3 Renal of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.4 Neurodegenerative of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.5 Respiratory of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.6 Genetic of Antisense and RNAi Therapeutics Growth Driving Factor Analysis
        7.3.7 Infectious Diseases of Antisense and RNAi Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antisense and RNAi Therapeutics
    8.1 Glaxo Smith Kline
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Glaxo Smith Kline 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Glaxo Smith Kline 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.2 Sanofi Aventis / Genzyme
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Sanofi Aventis / Genzyme 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Sanofi Aventis / Genzyme 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.4 Arbutus Biopharma Ltd.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Arbutus Biopharma Ltd. 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Arbutus Biopharma Ltd. 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.5 Silence Therapeutics
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Silence Therapeutics 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Silence Therapeutics 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.6 Bio-Path Holdings Inc.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Bio-Path Holdings Inc. 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bio-Path Holdings Inc. 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.7 Calando Pharmaceuticals
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Calando Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Calando Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.8 ICo Therapeutics
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 ICo Therapeutics 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 ICo Therapeutics 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.9 Quark Pharmaceuticals
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Quark Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Quark Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.10 Rexhan Pharmaceuticals
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Rexhan Pharmaceuticals 2016 Antisense and RNAi Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Rexhan Pharmaceuticals 2016 Antisense and RNAi Therapeutics Business Region Distribution Analysis
    8.11 Biomarin/Prosensa
    8.12 Regulus Therapeutics
    8.13 Rxi Pharmaceuticals
    8.14 Silenseed
    8.15 Dicerna Pharmaceuticals
    8.16 Sirnaomics Inc

9 Development Trend of Analysis of Antisense and RNAi Therapeutics Market
    9.1 Global Antisense and RNAi Therapeutics Market Trend Analysis
        9.1.1 Global  2019-2025 Antisense and RNAi Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global  2019-2025 Antisense and RNAi Therapeutics Sales Price Forecast
    9.2 Antisense and RNAi Therapeutics Regional Market Trend
        9.2.1 North America  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
        9.2.2 China  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
        9.2.3 Europe  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
        9.2.4 Southeast Asia  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
        9.2.5 Japan  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
        9.2.6 India  2019-2025 Antisense and RNAi Therapeutics Consumption Forecast
    9.3 Antisense and RNAi Therapeutics Market Trend (Product Type)
    9.4 Antisense and RNAi Therapeutics Market Trend (Application)

10 Antisense and RNAi Therapeutics Marketing Type Analysis
    10.1 Antisense and RNAi Therapeutics Regional Marketing Type Analysis
    10.2 Antisense and RNAi Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Antisense and RNAi Therapeutics by Region
    10.4 Antisense and RNAi Therapeutics Supply Chain Analysis

11 Consumers Analysis of Antisense and RNAi Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Antisense and RNAi Therapeutics Market Professional Survey  Report 2019
    Methodology
    Analyst Introduction
    Data Source